The Procter & Gamble Company(Listing date: 03/22/1950)
Procter & Gamble was incorporated in Ohio in 1905. The company is a global leader in the fast-moving consumer goods industry, focused on providing high-quality and valuable branded consumer packaged goods to consumers around the world. Its products are sold in more than 180 countries and regions primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, pharmacies, department stores, distributors, wholesalers, baby stores, professional beauty stores (including airport duty-free stores), high-frequency stores, electronics stores and professional channels. The company also sells products directly to consumers.
AI Value AnalystHold
Overall Rating6.3/10
Generated at:2026-06-03 17:40:50
Analysis based on real data for Procter & Gamble Company (The) (PG). Financial analysis uses 5 financial reports from periods ending 2026-03-31, 2025-12-31, 2025-09-30, 2025-06-30, and 2025-03-31. Market price data is as of 2026-06-04 close. TTM (Trailing Twelve Months) metrics are used for profitability and valuation analysis.
Overview
Procter & Gamble (PG) is a global leader in branded consumer packaged goods, operating in the resilient Consumer Defensive sector. The company demonstrates exceptional profitability with high margins and strong returns, but its valuation appears fair rather than undervalued, and its financial health shows mixed signals with potential liquidity concerns.
Valuation
4/10
Profitability
9/10
Financial health
6/10
Operation Advice
The stock is fairly valued at its current price of $140.19.
New investors should wait for a pullback closer to the $135 support level for a better entry point.
Existing shareholders can comfortably hold for long-term dividend income and capital preservation.
A 12-month fundamental target price of $148.00 is justified, representing potential upside of approximately 5.5% plus dividend yield.
Valuation
P/E TTM
20.90
P/E LYR
21.81
P/B MRQ
6.37
P/S TTM
--
AI Analysis
The valuation analysis indicates PG is fairly valued. The forward P/E of 21.81 and TTM P/E of 20.90 are within a reasonable historical range for a high-quality defensive company. The P/B ratio of 6.37 is high but justified by exceptional ROE. The current price sits at the lower end of the fundamental fair value range of $135-$155.
Current Market Price is $140.19 (as of 2026-06-04 close).
The forward P/E is 21.81 and the TTM P/E is 20.90, which is within a reasonable historical range for a high-quality, defensive consumer staples company.
The P/B ratio is 6.37, which is high in absolute terms but is justified by the company's exceptionally high ROE.
The P/S ratio is 3.76, which is typical for a company with PG's premium margins.
A strong support zone appears around $138.86 - $140.00.
Resistance is in the $147 - $149 range, with a higher spike to ~$152 in late April 2026.
Considering its defensive nature, stable earnings growth, and high profitability, a fundamental fair value range is approximately $135 - $155.
The current price of $140.19 sits at the lower end of the fair value range.
A 12-month fundamental target price of $148.00 is justified, representing a potential upside of approximately 5.5% from the current price, plus the dividend yield.
Valuation trend
Profitability
ROE TTM
31.54%
Net margin
19.84%
Gross margin
50.72%
Total revenue
65.83B
AI Analysis
Profitability analysis shows PG exhibits robust and stable profitability metrics. The TTM ROE of 31.54% is exceptionally high, indicating highly efficient use of shareholder equity. TTM ROA of 13.08% is strong. Margins are consistently high and stable, and recent reports show positive year-over-year growth.
Procter & Gamble exhibits robust and stable profitability metrics.
The TTM ROE of 31.54% is exceptionally high, indicating highly efficient use of shareholder equity to generate profits.
The TTM ROA of 13.08% is also strong, showing effective utilization of the company's total asset base.
Gross margins have consistently remained above 50%.
Net margins have been stable around 20% over the last five reported periods, demonstrating pricing power and strong cost management.
Recent quarterly reports show positive year-over-year growth in revenue, gross profit, and net income, indicating a steady growth trajectory.
The company demonstrates exceptional profitability with a net margin of 19.84% (as of Q3 2026).
Profitability
2025Q12025Q22025Q32025Q42026Q1
ROE TTM--31.23%9.02%17.27%31.54%
Earnings
2025Q12025Q22025Q32025Q42026Q1
Total revenue63.40B84.28B22.39B44.59B65.83B
Financial health
Debt/Asset
57.37%
Current ratio
0.73
Quick ratio
0.53
Cash ratio
0.53
AI Analysis
Financial condition assessment shows a mixed picture. The company has potential short-term liquidity constraints with current and quick ratios below ideal benchmarks. It has a moderate level of financial leverage with a debt-to-asset ratio of 57.37%. However, exceptional profitability supports strong operating cash flows.
The company's financial health shows a mixed picture of strength and potential concerns.
The current ratio of 0.73 and quick ratio of 0.53 are below the ideal benchmark of 1.0, indicating potential short-term liquidity constraints.
This liquidity profile is not uncommon for large, efficient corporations with strong cash flows but warrants monitoring.
The debt-to-asset ratio is 57.37%, indicating a moderate level of financial leverage.
This level of debt is manageable for a company of PG's scale and cash-generating ability but does increase financial risk.
The company demonstrates exceptional profitability with a net margin of 19.84%, which supports strong operating cash flows.
Strong operating cash flows are crucial for servicing debt, funding dividends, and investing in the business.